Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Long-Shot Breast Cancer Drug Now Promises Fortune, but Not for Big Pharma
Yahoo/Bloomberg
Fri, 07/25/14 - 05:57 pm
breast cancer
Pfizer
neratinib
Puma Biotechnology
Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
RTT News
Fri, 07/25/14 - 11:11 am
Bayer
ONYX Pharmaceuticals
Nexavar
breast cancer
Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla
Fierce Pharma
Fri, 07/25/14 - 09:18 am
Roche
breast cancer
Perjeta
Kadcyla
earnings
Prempro Plaintiffs’ Lawyers Settle $62 Million Fee Fight
Bloomberg
Wed, 07/23/14 - 09:11 am
Prempro
Pfizer
breast cancer
Arkansas
Puma Biotechnology shares more than triple on postive trial data
Marketwatch
Tue, 07/22/14 - 06:03 pm
Puma Biotechnology
breast cancer
neratinib
Roche's Deal Should Sound Early Warning
WSJ Online
Wed, 07/2/14 - 09:53 am
Roche
M&A
Seragon
breast cancer
Hologic's 3-D Mammogram Makes Better Breast Cancer Test, Study Says
Bloomberg
Tue, 06/24/14 - 04:49 pm
Hologic
3-D mammograms
breast cancer
Analyst: GlaxoSmithKline's Tykerb dead in the water after breast cancer failure
Fierce Pharma
Wed, 06/18/14 - 04:29 am
GSK
Tykerb
breast cancer
Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again
TheStreet.com
Fri, 06/13/14 - 11:00 am
Galena Biopharma
breast cancer
SEC
NeuVax
Genomic Health's Oncotype DX Redefines Breast Cancer Therapy
Yahoo/Zacks.com
Fri, 06/13/14 - 09:25 am
Oncotype DX
breast cancer
Genomic Health
diagnostics
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Fierce Biotech
Thu, 06/5/14 - 12:17 pm
Syndax Pharma
IPOs
breast cancer
breakthrough therapies
entinostat
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thu, 06/5/14 - 09:14 am
ASCO
Pfizer
Aromasin
tamoxifen
DARA Biosciences
breast cancer
Herceptin
Tykerb
GSK
Eli Lilly
Bristol-Myers Squibb
Erbitux
Rapid Path For Breast Cancer Drugs Need Not Be Blocked, Top Statistician Says
Forbes
Wed, 06/4/14 - 09:24 am
breast cancer
GSK
Tykerb
Herceptin
GTx reports results from Phase 2 study of enobosarm
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:58 pm
GTx
enobosarm
breast cancer
metastatic breast cancer
ASCO
Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:51 am
NKTR-214
Nektar
breast cancer
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/1/14 - 11:33 am
Puma Biotechnology
PB272
breast cancer
HER2-positive metastatic breast cancer
Clovis Oncology Announces Encouraging Data from Phase 1/2a Study Evaluating Lucitanib in Advanced Solid Tumors
Yahoo/BusinessWire
Sat, 05/31/14 - 10:09 am
Clovis Oncology
Lucitanib
breast cancer
non-small cell lung cancer
[video]Could This be Pfizer's Best Incoming Drug?
Motley Fool
Fri, 05/30/14 - 10:15 am
Pfizer
palbociclib
breast cancer
Pfizer seeks early approval for breast cancer drug
Yahoo/AP
Fri, 05/16/14 - 03:43 pm
breast cancer
Pfizer
palbociclib
Pfizer’s Pipeline: 2 Drugs That May Drive Future Revenues
Wall St Cheat Sheet
Mon, 05/5/14 - 05:06 pm
Pfizer
palbociclib
breast cancer
RN316
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »